Development of multicentric hepatocellular carcinoma after completion of interferon therapy

[1]  Valeer J Desmet,et al.  Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. , 2003, Journal of hepatology.

[2]  A. Oshima,et al.  Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: A retrospective cohort study of 738 patients , 2000, International journal of cancer.

[3]  Y. Liaw,et al.  Activation of nuclear factor κB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis , 2000, Hepatology.

[4]  Yasuyuki Arakawa,et al.  Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan , 1999, Annals of Internal Medicine.

[5]  K. Shimotohno,et al.  Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-κB Activation , 1999, Journal of Virology.

[6]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.

[7]  N. Hayashi,et al.  Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C , 1998, Hepatology.

[8]  P. Pineau,et al.  Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma. , 1998, The Journal of general virology.

[9]  A. Onitsuka,et al.  Rapid growth of hepatocellular carcinoma after or during interferon treatment for chronic hepatitis C: Report of three cases , 1996, Surgery Today.

[10]  S. Seki,et al.  Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis , 1995, The Lancet.

[11]  Y. Hayashi,et al.  Clinicopathological study of minimum‐sized hepatocellular carcinoma: An approach to the definition of early hepatocellular carcinoma , 1995, Journal of gastroenterology and hepatology.

[12]  M. Soldan,et al.  [Recombinant interferon alfa in the treatment of chronic hepatitis C]. , 1995, Revista da Associacao Medica Brasileira.

[13]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[14]  M Kitagawa,et al.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2 , 1993, Science.

[15]  H. Okamoto,et al.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. , 1992, The Journal of general virology.

[16]  T. Hasuma,et al.  Reduction by interferon-alpha of levels of c-myc protein and DNA synthesis in a human hepatoma cell line mediated by inhibition of putrescine synthesis. , 1991, Biochemical and biophysical research communications.

[17]  M. Houghton,et al.  A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan , 1991, Cancer.

[18]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[19]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[20]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.

[21]  H. Thomas,et al.  Natural killer cell activity in hepatocellular carcinoma. In vitro and in vivo responses to interferon. , 1987, Scandinavian journal of gastroenterology.

[22]  J. Hoofnagle,et al.  Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. , 1986, The New England journal of medicine.

[23]  Kenichi Kobayashi,et al.  Interferon production by peripheral lymphocytes in HBsAg‐positive liver diseases , 1982, Hepatology.

[24]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[25]  N. Minato,et al.  Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Shimotohno,et al.  Hepatitis C Virus Core Protein Inhibits Fas-and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NFk B Activation , 1999 .

[27]  M. Houghton,et al.  A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. , 1991, Cancer.